The Role of Inflammation in Venous Thromboembolism

Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT), and pulmonary embolism (PE), is becoming increasingly recognized as a cause of morbidity and mortality in pediatrics, particularly among hospitalized children. Furthermore, evidence is accumulating that suggests the inflammatory re...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Frontiers in pediatrics Ročník 6; s. 142
Hlavní autori: Branchford, Brian R., Carpenter, Shannon L.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Switzerland Frontiers Media S.A 23.05.2018
Predmet:
ISSN:2296-2360, 2296-2360
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT), and pulmonary embolism (PE), is becoming increasingly recognized as a cause of morbidity and mortality in pediatrics, particularly among hospitalized children. Furthermore, evidence is accumulating that suggests the inflammatory response may be a cause, as well as consequence, of VTE, but current anticoagulation treatment regimens are not designed to inhibit inflammation. In fact, many established clinical VTE risk factors such as surgery, obesity, cystic fibrosis, sepsis, systemic infection, cancer, inflammatory bowel disease, and lupus likely modulate thrombosis through inflammatory mediators. Unlike other traumatic mechanisms of thrombosis involving vascular transection and subsequent exposure of subendothelial collagen and other procoagulant extracellular matrix materials, inflammation of the vessel wall may initiate thrombosis on an intact vein. Activation of endothelial cells, platelets, and leukocytes with subsequent formation of microparticles can trigger the coagulation system through the induction of tissue factor (TF). Identification of biomarkers to evaluate VTE risk could be of great use to the clinician caring for a patient with inflammatory disease to guide decisions regarding the risk:benefit ratio of various types of potential thromboprophylaxis strategies, or suggest a role for anti-inflammatory therapy. Unfortunately, no such validated inflammatory scoring system yet exists, though research in this area is ongoing. Elevation of C-reactive protein, IL-6, IL-8, and TNF-alpha during a response to systemic inflammation have been associated with increased VTE risk. Consequent platelet activation enhances the prothrombotic state, leading to VTE development, particularly in patients with other risk factors, most notably central venous catheters.
AbstractList Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT), and pulmonary embolism (PE), is becoming increasingly recognized as a cause of morbidity and mortality in pediatrics, particularly among hospitalized children. Furthermore, evidence is accumulating that suggests the inflammatory response may be a cause, as well as consequence, of VTE, but current anticoagulation treatment regimens are not designed to inhibit inflammation. In fact, many established clinical VTE risk factors such as surgery, obesity, cystic fibrosis, sepsis, systemic infection, cancer, inflammatory bowel disease, and lupus likely modulate thrombosis through inflammatory mediators. Unlike other traumatic mechanisms of thrombosis involving vascular transection and subsequent exposure of subendothelial collagen and other procoagulant extracellular matrix materials, inflammation of the vessel wall may initiate thrombosis on an intact vein. Activation of endothelial cells, platelets, and leukocytes with subsequent formation of microparticles can trigger the coagulation system through the induction of tissue factor (TF). Identification of biomarkers to evaluate VTE risk could be of great use to the clinician caring for a patient with inflammatory disease to guide decisions regarding the risk:benefit ratio of various types of potential thromboprophylaxis strategies, or suggest a role for anti-inflammatory therapy. Unfortunately, no such validated inflammatory scoring system yet exists, though research in this area is ongoing. Elevation of C-reactive protein, IL-6, IL-8, and TNF-alpha during a response to systemic inflammation have been associated with increased VTE risk. Consequent platelet activation enhances the prothrombotic state, leading to VTE development, particularly in patients with other risk factors, most notably central venous catheters.
Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT), and pulmonary embolism (PE), is becoming increasingly recognized as a cause of morbidity and mortality in pediatrics, particularly among hospitalized children. Furthermore, evidence is accumulating that suggests the inflammatory response may be a cause, as well as consequence, of VTE, but current anticoagulation treatment regimens are not designed to inhibit inflammation. In fact, many established clinical VTE risk factors such as surgery, obesity, cystic fibrosis, sepsis, systemic infection, cancer, inflammatory bowel disease, and lupus likely modulate thrombosis through inflammatory mediators. Unlike other traumatic mechanisms of thrombosis involving vascular transection and subsequent exposure of subendothelial collagen and other procoagulant extracellular matrix materials, inflammation of the vessel wall may initiate thrombosis on an intact vein. Activation of endothelial cells, platelets, and leukocytes with subsequent formation of microparticles can trigger the coagulation system through the induction of tissue factor (TF). Identification of biomarkers to evaluate VTE risk could be of great use to the clinician caring for a patient with inflammatory disease to guide decisions regarding the risk:benefit ratio of various types of potential thromboprophylaxis strategies, or suggest a role for anti-inflammatory therapy. Unfortunately, no such validated inflammatory scoring system yet exists, though research in this area is ongoing. Elevation of C-reactive protein, IL-6, IL-8, and TNF-alpha during a response to systemic inflammation have been associated with increased VTE risk. Consequent platelet activation enhances the prothrombotic state, leading to VTE development, particularly in patients with other risk factors, most notably central venous catheters.Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT), and pulmonary embolism (PE), is becoming increasingly recognized as a cause of morbidity and mortality in pediatrics, particularly among hospitalized children. Furthermore, evidence is accumulating that suggests the inflammatory response may be a cause, as well as consequence, of VTE, but current anticoagulation treatment regimens are not designed to inhibit inflammation. In fact, many established clinical VTE risk factors such as surgery, obesity, cystic fibrosis, sepsis, systemic infection, cancer, inflammatory bowel disease, and lupus likely modulate thrombosis through inflammatory mediators. Unlike other traumatic mechanisms of thrombosis involving vascular transection and subsequent exposure of subendothelial collagen and other procoagulant extracellular matrix materials, inflammation of the vessel wall may initiate thrombosis on an intact vein. Activation of endothelial cells, platelets, and leukocytes with subsequent formation of microparticles can trigger the coagulation system through the induction of tissue factor (TF). Identification of biomarkers to evaluate VTE risk could be of great use to the clinician caring for a patient with inflammatory disease to guide decisions regarding the risk:benefit ratio of various types of potential thromboprophylaxis strategies, or suggest a role for anti-inflammatory therapy. Unfortunately, no such validated inflammatory scoring system yet exists, though research in this area is ongoing. Elevation of C-reactive protein, IL-6, IL-8, and TNF-alpha during a response to systemic inflammation have been associated with increased VTE risk. Consequent platelet activation enhances the prothrombotic state, leading to VTE development, particularly in patients with other risk factors, most notably central venous catheters.
Author Carpenter, Shannon L.
Branchford, Brian R.
AuthorAffiliation 1 University of Colorado Hemophilia and Thrombosis Center, Pediatric Hematology, University of Colorado School of Medicine and Children's Hospital Colorado , Aurora, CO , United States
2 Kansas City Regional Hemophilia Treatment Center, Pediatric Hematology, UMKC School of Medicine and Children's Mercy Hospital , Kansas, CO , United States
AuthorAffiliation_xml – name: 2 Kansas City Regional Hemophilia Treatment Center, Pediatric Hematology, UMKC School of Medicine and Children's Mercy Hospital , Kansas, CO , United States
– name: 1 University of Colorado Hemophilia and Thrombosis Center, Pediatric Hematology, University of Colorado School of Medicine and Children's Hospital Colorado , Aurora, CO , United States
Author_xml – sequence: 1
  givenname: Brian R.
  surname: Branchford
  fullname: Branchford, Brian R.
– sequence: 2
  givenname: Shannon L.
  surname: Carpenter
  fullname: Carpenter, Shannon L.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29876337$$D View this record in MEDLINE/PubMed
BookMark eNp1UU1rXCEUlZLSfDTr7spbZjMT9alPN4UQ2mQgECjTbsXPjMGnU30T6L-v85GQFCJcvOg5517OOQVHKScHwBcE533PxaVfOzvHEPE5hIjgD-AEY8FmuGfw6FV_DM5rfYTtiAFSRD-BYyz4wPp-OAF4uXLdzxxdl323SD6qcVRTyKkLqfvtUt7UbrkqedTZtYqhjp_BR69ideeH-wz8-vF9eX07u7u_WVxf3c0MxXSaaaOs9hgZj6A3BCHbC66N1Y54QrXWlgzKDoJpZJDlChvhWINATpVVnPZnYLHXtVk9ynUJoyp_ZVZB7h5yeZCqTMFEJzHXzhtoOKWKCOQFEpQpAb1vZRhrWt_2WuuNHp01Lk1FxTeib39SWMmH_CSpGAiCsAlcHARK_rNxdZJjqMbFqJJrHkncnGV0IGS799fXs16GPJveAJd7gCm51uL8CwRBuU1WbpOV22TlLtnGoP8xTJh2MbVlQ3yX9w9i6ai2
CitedBy_id crossref_primary_10_3390_jcm10184190
crossref_primary_10_2147_IJGM_S261718
crossref_primary_10_1111_crj_13176
crossref_primary_10_1016_j_phrs_2019_04_013
crossref_primary_10_1007_s11239_020_02242_0
crossref_primary_10_3389_fmed_2023_1011936
crossref_primary_10_1093_ehjacc_zuaf109
crossref_primary_10_3892_ijmm_2023_5255
crossref_primary_10_1097_MD_0000000000040680
crossref_primary_10_3389_fvets_2022_844022
crossref_primary_10_1016_j_envpol_2022_119469
crossref_primary_10_1016_j_diabres_2022_110190
crossref_primary_10_1186_s13018_023_03518_w
crossref_primary_10_1186_s13018_023_03966_4
crossref_primary_10_3390_medicina61061095
crossref_primary_10_1016_j_jtha_2022_11_024
crossref_primary_10_1007_s00204_020_02959_0
crossref_primary_10_3233_CH_190735
crossref_primary_10_1080_17474124_2022_2072295
crossref_primary_10_1016_j_jpedsurg_2020_02_020
crossref_primary_10_3389_fneur_2023_1189898
crossref_primary_10_3390_ijms21145086
crossref_primary_10_1017_S1047951119002932
crossref_primary_10_1007_s11239_022_02711_8
crossref_primary_10_1542_hpeds_2022_006697
crossref_primary_10_3390_molecules26134102
crossref_primary_10_1155_2022_6909764
crossref_primary_10_3389_fmed_2023_1320015
crossref_primary_10_4187_respcare_11698
crossref_primary_10_1055_s_0044_1801825
crossref_primary_10_1177_1076029621993573
crossref_primary_10_1177_10760296221130061
crossref_primary_10_3233_CH_201030
crossref_primary_10_1016_j_jconrel_2020_12_009
crossref_primary_10_1007_s10753_023_01848_9
crossref_primary_10_3390_jcm11061538
crossref_primary_10_1097_NR9_0000000000000047
crossref_primary_10_1016_j_cytogfr_2021_10_007
crossref_primary_10_1016_j_idc_2022_01_003
crossref_primary_10_1016_j_thromres_2020_05_014
crossref_primary_10_1001_jamadermatol_2021_1570
crossref_primary_10_1002_adhm_202301039
crossref_primary_10_3390_biom12050681
crossref_primary_10_1007_s00210_024_03453_5
crossref_primary_10_1016_j_amjms_2021_09_002
crossref_primary_10_1111_ijcp_14966
crossref_primary_10_1111_jth_15657
crossref_primary_10_3390_molecules27248919
crossref_primary_10_1177_10760296241275138
crossref_primary_10_1016_j_ijbiomac_2025_145259
crossref_primary_10_1016_j_jpeds_2020_06_022
crossref_primary_10_1016_j_thromres_2024_109169
crossref_primary_10_7759_cureus_14722
crossref_primary_10_3390_ijms22052627
crossref_primary_10_7759_cureus_18528
crossref_primary_10_1177_10760296221104801
crossref_primary_10_36290_vnl_2020_153
crossref_primary_10_1007_s11655_023_3630_3
crossref_primary_10_1016_j_thromres_2020_01_022
crossref_primary_10_2147_JBM_S291226
crossref_primary_10_1007_s11596_024_2862_6
crossref_primary_10_1016_j_prrv_2020_04_007
crossref_primary_10_3390_ijms22116153
crossref_primary_10_1080_1354750X_2019_1600021
crossref_primary_10_1136_rmdopen_2019_001013
crossref_primary_10_1186_s12959_024_00682_9
crossref_primary_10_1016_j_avsg_2022_09_056
crossref_primary_10_1259_bjr_20190526
crossref_primary_10_1155_2021_6678167
crossref_primary_10_3389_fninf_2022_1052868
crossref_primary_10_1016_j_jvir_2021_09_009
crossref_primary_10_1161_ATVBAHA_119_312463
crossref_primary_10_1111_cei_13243
crossref_primary_10_3389_fcvm_2021_729298
crossref_primary_10_1186_s12876_022_02632_z
crossref_primary_10_1097_AOG_0000000000004959
crossref_primary_10_3390_jcm11195934
crossref_primary_10_3389_fimmu_2023_1044444
crossref_primary_10_4103_HUAJ_HUAJ_26_22
crossref_primary_10_1016_j_jtha_2023_06_035
crossref_primary_10_1002_rth2_12143
crossref_primary_10_1186_s13148_019_0665_6
crossref_primary_10_1161_ATVBAHA_121_316153
crossref_primary_10_1097_MD_0000000000044311
crossref_primary_10_1097_MPG_0000000000003747
crossref_primary_10_1111_aos_15051
crossref_primary_10_1155_2020_1935742
crossref_primary_10_3389_fcvm_2021_655226
crossref_primary_10_59556_japi_72_0737
crossref_primary_10_1016_j_ejim_2023_10_014
crossref_primary_10_3390_antiox10111696
crossref_primary_10_1055_a_1674_0259
crossref_primary_10_1016_j_cpet_2022_03_003
crossref_primary_10_3390_antiox13060727
crossref_primary_10_3389_fimmu_2019_02204
crossref_primary_10_1002_smll_202003401
crossref_primary_10_1016_j_bbcan_2025_189457
crossref_primary_10_1093_jalm_jfab094
crossref_primary_10_1016_j_avsg_2024_06_005
crossref_primary_10_3389_fcvm_2024_1398614
crossref_primary_10_1016_j_heliyon_2025_e42928
crossref_primary_10_1186_s13018_022_03457_y
crossref_primary_10_2147_JIR_S258839
crossref_primary_10_3389_fmolb_2023_1325002
crossref_primary_10_2147_CMAR_S533589
crossref_primary_10_3390_jcm14113965
crossref_primary_10_1055_s_0041_1732372
crossref_primary_10_3390_jpm13010020
crossref_primary_10_1097_PCC_0000000000003383
crossref_primary_10_1186_s13256_025_05084_7
crossref_primary_10_7759_cureus_38169
crossref_primary_10_1097_MD_0000000000019814
crossref_primary_10_1177_03000605241240999
crossref_primary_10_3390_ijms24108945
crossref_primary_10_1111_ene_70047
crossref_primary_10_7759_cureus_25779
crossref_primary_10_3390_cells14171319
crossref_primary_10_1016_j_ajem_2020_09_065
crossref_primary_10_1016_j_ejogrb_2024_05_011
crossref_primary_10_1016_j_thromres_2021_01_005
crossref_primary_10_1016_j_hrtlng_2025_03_004
crossref_primary_10_1177_10760296221091770
crossref_primary_10_3390_medicina58081078
crossref_primary_10_1186_s12891_022_05377_8
crossref_primary_10_3390_ijms242417440
crossref_primary_10_1007_s12012_024_09893_y
crossref_primary_10_1016_j_jns_2021_119988
crossref_primary_10_1007_s10072_023_06853_2
crossref_primary_10_1016_j_cca_2019_02_008
crossref_primary_10_3390_antiox9121217
crossref_primary_10_3389_fcvm_2024_1356286
crossref_primary_10_3390_ijms24021010
crossref_primary_10_1016_j_thromres_2019_03_008
crossref_primary_10_1016_j_tcam_2020_100490
crossref_primary_10_1111_jvim_16044
crossref_primary_10_1186_s13054_023_04683_4
crossref_primary_10_1182_blood_2023022329
crossref_primary_10_3390_ijms21217975
crossref_primary_10_1007_s12291_021_00972_3
crossref_primary_10_1084_jem_20202579
crossref_primary_10_1002_clc_23833
crossref_primary_10_1097_MBC_0000000000000900
crossref_primary_10_2106_JBJS_21_01531
crossref_primary_10_1016_j_avsg_2022_03_002
crossref_primary_10_1097_MD_0000000000036220
crossref_primary_10_1038_s41569_020_0347_2
crossref_primary_10_1186_s12890_020_01216_5
crossref_primary_10_1097_SHK_0000000000002216
crossref_primary_10_1186_s12890_021_01632_1
crossref_primary_10_1016_j_msard_2022_103513
crossref_primary_10_3892_mmr_2019_9909
crossref_primary_10_1038_s41598_025_09255_w
crossref_primary_10_1055_a_1177_5127
crossref_primary_10_3892_br_2024_1784
crossref_primary_10_1016_j_heliyon_2024_e28389
crossref_primary_10_1186_s12959_023_00497_0
crossref_primary_10_1016_j_cca_2024_119976
crossref_primary_10_1177_10760296211013107
crossref_primary_10_1016_j_amjsurg_2020_06_068
crossref_primary_10_1177_02184923231167310
crossref_primary_10_2147_IJGM_S395745
crossref_primary_10_3389_fimmu_2022_1037255
crossref_primary_10_1038_s41467_024_52262_0
crossref_primary_10_1186_s42444_024_00110_z
crossref_primary_10_1016_j_jvsv_2020_05_018
crossref_primary_10_1016_j_clinimag_2021_06_025
crossref_primary_10_1016_j_thromres_2024_03_009
crossref_primary_10_1080_16078454_2024_2423438
crossref_primary_10_1093_ecco_jcc_jjab171
crossref_primary_10_1016_j_thromres_2022_06_012
crossref_primary_10_1016_j_rpth_2024_102541
crossref_primary_10_1007_s00414_020_02441_7
crossref_primary_10_1016_j_thromres_2020_03_003
crossref_primary_10_1021_acs_est_4c13457
crossref_primary_10_1053_j_ajkd_2020_05_004
crossref_primary_10_1093_asj_sjac195
crossref_primary_10_1136_bcr_2021_243697
crossref_primary_10_1186_s12959_024_00599_3
crossref_primary_10_3390_antiox11081618
crossref_primary_10_2147_IJGM_S372038
crossref_primary_10_3389_fimmu_2022_918476
crossref_primary_10_1016_j_blre_2023_101075
crossref_primary_10_1055_s_0040_1714399
crossref_primary_10_1055_s_0041_1729170
crossref_primary_10_3390_cancers13153837
crossref_primary_10_1016_j_genrep_2022_101630
crossref_primary_10_1093_ibd_izz170
crossref_primary_10_5114_ait_2020_97599
crossref_primary_10_1016_j_rpth_2025_103004
crossref_primary_10_1186_s12883_025_04137_0
crossref_primary_10_30702_ujcvs_22_30_04__GR058_115121
crossref_primary_10_3390_cells9112473
crossref_primary_10_1186_s12959_023_00473_8
crossref_primary_10_1097_GH9_0000000000000206
crossref_primary_10_1186_s40981_020_00328_5
crossref_primary_10_3389_fcvm_2022_938397
crossref_primary_10_1093_bjd_ljad212
crossref_primary_10_1055_s_0041_1722992
crossref_primary_10_3390_life14070865
crossref_primary_10_1111_bjd_21704
crossref_primary_10_1016_j_ijid_2020_08_083
crossref_primary_10_1177_10760296211052292
crossref_primary_10_1371_journal_pone_0316628
crossref_primary_10_3390_jcm10102061
crossref_primary_10_1016_j_thromres_2022_09_015
crossref_primary_10_4103_lungindia_lungindia_409_21
crossref_primary_10_1080_1744666X_2023_2157262
crossref_primary_10_1097_TA_0000000000004713
crossref_primary_10_1080_21655979_2021_1917980
crossref_primary_10_1016_j_mvr_2022_104408
crossref_primary_10_3390_jcm11174948
crossref_primary_10_1177_1076029620945398
crossref_primary_10_1161_CIRCRESAHA_121_318173
crossref_primary_10_1007_s10072_020_05007_y
crossref_primary_10_1016_j_amjmed_2020_04_033
crossref_primary_10_3390_diagnostics15172134
crossref_primary_10_1182_blood_2022016424
crossref_primary_10_1111_jth_14835
crossref_primary_10_1161_ATVBAHA_119_313137
crossref_primary_10_3390_cancers11122020
crossref_primary_10_1016_j_jvsv_2023_02_008
crossref_primary_10_7759_cureus_12056
crossref_primary_10_1186_s12964_023_01110_7
crossref_primary_10_3390_ijms20112838
crossref_primary_10_1016_j_wneu_2024_05_048
crossref_primary_10_1182_blood_2020007155
crossref_primary_10_1016_j_jvsv_2019_05_007
crossref_primary_10_1038_s42003_023_04492_z
crossref_primary_10_1590_1806_9282_20221211
crossref_primary_10_1136_rmdopen_2020_001392
crossref_primary_10_1155_2020_3086906
crossref_primary_10_1186_s12959_025_00705_z
crossref_primary_10_1016_j_semarthrit_2021_10_001
crossref_primary_10_1155_2022_5672384
crossref_primary_10_1016_j_jvsv_2020_06_019
crossref_primary_10_1002_ccr3_3112
crossref_primary_10_12998_wjcc_v12_i21_4820
crossref_primary_10_1590_1806_9282_20240649
crossref_primary_10_3390_cells11030359
crossref_primary_10_1007_s00277_025_06234_z
crossref_primary_10_2217_bmm_2023_0741
crossref_primary_10_3389_fimmu_2019_03150
crossref_primary_10_1002_iid3_769
crossref_primary_10_3390_diagnostics14171994
crossref_primary_10_1016_j_jtha_2025_01_006
crossref_primary_10_1016_j_rmed_2020_106072
crossref_primary_10_1016_j_humimm_2019_05_001
crossref_primary_10_3390_ijms21062080
crossref_primary_10_3390_ph15080931
crossref_primary_10_1371_journal_pone_0319928
crossref_primary_10_1186_s12935_023_02882_1
crossref_primary_10_1016_j_ijnurstu_2022_104341
crossref_primary_10_3748_wjg_v28_i16_1705
crossref_primary_10_3892_mmr_2022_12652
Cites_doi 10.1016/j.thromres.2015.11.029
10.1016/j.otsr.2010.05.006
10.1186/s13075-014-0435-y
10.1016/S0140-6736(05)71880-8
10.1111/j.1538-7836.2011.04354.x
10.1182/blood-2013-05-427708
10.1038/nri3345
10.1023/A:1018895500721
10.1002/ibd.20759
10.1159/000068427
10.1016/S0008-6363(02)00857-X
10.1111/ijlh.12349
10.1007/s00281-011-0286-4
10.1161/CIRCGENETICS.108.801969
10.1111/jth.13871
10.1016/j.jcf.2014.05.015
10.1055/s-0034-1398376
10.1083/jcb.39.1.152
10.1097/00043426-198406020-00017
10.1016/j.thromres.2017.08.022
10.1007/s12185-012-1054-5
10.1016/j.humpath.2006.11.017
10.1055/s-0033-1343886
10.1111/j.1600-0625.1999.tb00342.x
10.1200/JCO.2005.05.5343
10.1161/ATVBAHA.111.242859
10.1002/ppul.21566
10.1160/TH16-04-0323
10.1097/DCR.0000000000000054
10.1160/TH09-04-0274
10.1111/jth.13235
10.1182/blood-2016-05-716720
10.1111/j.1538-7836.2011.04323.x
10.1097/00132586-199212000-00035
10.2741/1184
10.1111/j.1538-7836.2004.00689.x
10.1016/j.jvs.2007.08.037
10.1161/ATVBAHA.108.162289
10.1136/gut.32.8.913
10.1093/rheumatology/keu408
10.5402/2012/428269
10.1160/TH14-06-0515
10.1111/jth.12742
10.1186/s12959-015-0043-3
10.1161/01.CIR.0000150639.98514.6c
10.1177/0268355515607405
10.1378/chest.11-2297
10.1067/mva.2002.128636
10.1038/ajg.2011.53
10.1016/j.intimp.2015.07.044
10.1017/S1462399411001943
10.4172/2161-105X.1000143
10.1038/nchembio.124
10.1164/rccm.200508-1243PP
10.1055/s-0033-1343894
10.1111/j.1524-475X.2008.00410.x
10.1016/j.thromres.2013.12.021
10.1177/1358863X14568706
10.1055/s-0037-1617146
10.1189/jlb.0607373
10.1186/s12959-015-0048-y
10.1097/00000658-198904000-00015
10.1097/MOH.0b013e3283634443
10.1016/j.jvs.2005.04.045
10.1016/j.jpeds.2005.11.032
10.1016/j.ejim.2015.06.005
10.1001/jamainternmed.2013.122
10.1007/s00018-009-0205-1
10.1186/s12959-015-0044-2
10.1016/j.thromres.2011.04.016
10.1182/blood-2014-09-601641
10.1182/asheducation-2014.1.60
10.1146/annurev-physiol-042210-121137
10.1172/jci.insight.89384
10.1161/CIRCRESAHA.116.306853
10.1007/s00134-013-3054-1
10.3760/cma.j.issn.0366-6999.2012.22.016
10.1111/jth.12571
10.1111/j.1538-7836.2008.02901.x
ContentType Journal Article
Copyright Copyright © 2018 Branchford and Carpenter. 2018 Branchford and Carpenter
Copyright_xml – notice: Copyright © 2018 Branchford and Carpenter. 2018 Branchford and Carpenter
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fped.2018.00142
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2296-2360
ExternalDocumentID oai_doaj_org_article_28befc0c855a491f91956a90ff90fc66
PMC5974100
29876337
10_3389_fped_2018_00142
Genre Journal Article
Review
GroupedDBID 53G
5VS
9T4
AAFWJ
AAYXX
ACGFO
ACGFS
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
ACXDI
EMOBN
IAO
IEA
IHR
IHW
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c525t-bcadbf21cf10fc411d398bcdbe4f45bbbd47ad796b1c1d8a2c9e6398085ada853
IEDL.DBID DOA
ISICitedReferencesCount 247
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000432836100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2296-2360
IngestDate Fri Oct 03 12:51:25 EDT 2025
Thu Aug 21 18:31:34 EDT 2025
Fri Sep 05 12:27:08 EDT 2025
Wed Feb 19 02:42:15 EST 2025
Sat Nov 29 02:51:28 EST 2025
Tue Nov 18 22:30:59 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords risk factors
thrombosis
inflammation
venous thromboembolism
pediatrics
cytokines
platelets
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c525t-bcadbf21cf10fc411d398bcdbe4f45bbbd47ad796b1c1d8a2c9e6398085ada853
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Reviewed by: Cameron C. Trenor, Boston Children's Hospital, Harvard University, United States; Leo D. Wang, City of Hope National Medical Center, United States
This article was submitted to Pediatric Hematology and Hematological Malignancies, a section of the journal Frontiers in Pediatrics
Edited by: Birgit Knoechel, Dana–Farber Cancer Institute, United States
OpenAccessLink https://doaj.org/article/28befc0c855a491f91956a90ff90fc66
PMID 29876337
PQID 2051657445
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_28befc0c855a491f91956a90ff90fc66
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5974100
proquest_miscellaneous_2051657445
pubmed_primary_29876337
crossref_primary_10_3389_fped_2018_00142
crossref_citationtrail_10_3389_fped_2018_00142
PublicationCentury 2000
PublicationDate 2018-05-23
PublicationDateYYYYMMDD 2018-05-23
PublicationDate_xml – month: 05
  year: 2018
  text: 2018-05-23
  day: 23
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in pediatrics
PublicationTitleAlternate Front Pediatr
PublicationYear 2018
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Monn (B3) 2014; 57
Schouten (B10) 2008; 83
Barrientos (B59) 2008; 16
Barbul (B58) 1989; 209
Culmer (B66) 2017; 117
Afshar (B77) 2013; 3
Date (B34) 2017; 15
Walker (B15) 2014; 133
Morrissey (B43) 2012; 95
Dionne (B68) 1997; 42
Fuchs (B47) 2012; 32
Burk (B73) 1992; 89
Lee (B22) 2014; 16
Koh (B55) 2011; 13
Wang (B61) 2016; 1
Blokhin (B72) 2013; 20
Levi (B9) 2013; 39
Diegelmann (B60) 2004; 9
Kyrle (B32) 2005; 365
Semple (B49) 2010; 67
Travers (B44) 2015; 37
Takemoto (B6) 2012; 47
Engelmann (B48) 2013; 13
Raffini (B76) 2006; 148
Meissner (B37) 2007; 46
Koutroumpakis (B17) 2013; 39
Levi (B78) 2015; 41
Murch (B67) 1991; 32
van Montfoort (B30) 2014; 2014
Matos (B27) 2011; 128
Murthy (B18) 2011; 106
Kuhle (B14) 2008; 6
Levi (B12) 2003; 60
Ungprasert (B52) 2015; 54
Xu (B45) 2010; 30
Kantar (B54) 2015; 26
Levi (B8) 2013; 39
Bazzan (B20) 2015; 16
Currimbhoy (B74) 1984; 6
Esmon (B46) 2011; 9
Poredos (B28) 2007; 26
Myers (B65) 2002; 36
Folsom (B24) 2009; 102
Reitsma (B62) 2004; 2
Manly (B35) 2011; 73
Docampo (B42) 2014; 124
Wakefield (B33) 2008; 28
Schmidt (B51) 2011; 9
Agnelli (B1) 2004; 110
Giannotta (B16) 2015; 13
Artuc (B57) 1999; 8
Journeycake (B13) 2006; 24
Munck (B5) 2015; 14
Kroegel (B36) 2003; 70
Bouchoucha (B81) 2010; 96
Choi (B41) 2015; 113
Saghazadeh (B23) 2015; 28
Bernard (B38) 2007; 38
Cheng (B39) 2007; 87
Zee (B82) 2009; 2
Knight-Perry (B7) 2017; 158
Long (B29) 2016; 14
Erkan (B21) 2006; 33
Ross (B56) 1968; 39
Myers (B64) 2005; 42
Gao (B25) 2016; 31
Al-Homood (B19) 2012; 2012
Gould (B2) 2012; 141
Kastrup (B80) 2008; 4
Piazza (B40) 2015; 20
O'Sullivan (B75) 2006; 173
Savchenko (B63) 2014; 12
Carpenter (B11) 2016; 138
Johannesdottir (B53) 2013; 173
Olson (B4) 2014; 12
Lentz (B70) 2016; 128
Matsuda (B69) 2009; 15
Foley (B79) 2016; 118
Mahemuti (B26) 2012; 125
Wu (B31) 2015; 13
Vieira-de-Abreu (B50) 2012; 34
Samad (B71) 2013; 122
29028284 - J Thromb Haemost. 2017 Dec;15(12 ):2289-2299
12584387 - Respiration. 2003 Jan-Feb;70(1):7-30
21592304 - J Thromb Haemost. 2011 Jul;9(7):1326-33
22315263 - Chest. 2012 Feb;141(2 Suppl):e227S-e277S
23625756 - Semin Thromb Hemost. 2013 Jul;39(5):559-66
26253657 - Int Immunopharmacol. 2015 Sep;28(1):655-65
24608307 - Dis Colon Rectum. 2014 Apr;57(4):497-505
22652600 - Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1777-83
25976958 - Int J Lab Hematol. 2015 May;37 Suppl 1:31-5
25832597 - Vasc Med. 2015 Apr;20(2):102-4
28300869 - Thromb Haemost. 2017 Jun 2;117(6):1171-1181
18091697 - Int Angiol. 2007 Dec;26(4):306-11
20162248 - Hamostaseologie. 2010 Jan;30(1):5-6, 8-9
28934665 - Thromb Res. 2017 Oct;158:161-166
24092932 - Blood. 2013 Nov 14;122(20):3415-22
5678446 - J Cell Biol. 1968 Oct;39(1):152-68
17008698 - J Clin Oncol. 2006 Oct 1;24(28):4575-80
15102017 - J Thromb Haemost. 2004 Apr;2(4):619-22
23817170 - Curr Opin Hematol. 2013 Sep;20(5):437-44
22900201 - ISRN Rheumatol. 2012;2012:428269
23158132 - Chin Med J (Engl). 2012 Nov;125(22):3997-4002
27126649 - Circ Res. 2016 Apr 29;118(9):1392-408
25908929 - Thromb J. 2015 Apr 23;13:16
21740602 - Expert Rev Mol Med. 2011 Jul 11;13:e23
17350667 - Hum Pathol. 2007 Jun;38(6):871-7
21407182 - Am J Gastroenterol. 2011 Apr;106(4):713-8
15598646 - Circulation. 2004 Dec 14;110(24 Suppl 1):IV4-12
16960931 - J Rheumatol. 2006 Sep;33(9):1715-7
25866483 - Thromb J. 2015 Apr 02;13:14
23629820 - Semin Thromb Hemost. 2013 Jul;39(5):461-8
24388573 - Thromb Res. 2014 Mar;133(3):340-4
27856470 - Blood. 2016 Nov 17;128(20):2388-2394
21818701 - Semin Immunopathol. 2012 Jan;34(1):5-30
26405065 - Phlebology. 2016 Oct;31(9):625-31
16102635 - J Vasc Surg. 2005 Aug;42(2):329-36
2522759 - Ann Surg. 1989 Apr;209(4):479-83
20690821 - Annu Rev Physiol. 2011;73:515-25
16339920 - Am J Respir Crit Care Med. 2006 Mar 1;173(5):483-90
25292154 - J Thromb Haemost. 2014 Dec;12(12):1993-2001
25253302 - Arthritis Res Ther. 2014 Sep 25;16(5):435
18194413 - J Thromb Haemost. 2008 Apr;6(4):589-94
12422103 - J Vasc Surg. 2002 Nov;36(5):928-38
18296594 - Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):387-91
24674135 - J Thromb Haemost. 2014 Jun;12(6):860-70
14766366 - Front Biosci. 2004 Jan 01;9:283-9
18036322 - Zhonghua Yi Xue Za Zhi. 2007 Sep 11;87(34):2420-2
19806245 - Thromb Haemost. 2009 Oct;102(4):615-9
18942752 - Inflamm Bowel Dis. 2009 Mar;15(3):328-34
10206716 - Exp Dermatol. 1999 Feb;8(1):1-16
23925547 - Intensive Care Med. 2013 Oct;39(10 ):1839-42
9246063 - Dig Dis Sci. 1997 Jul;42(7):1557-66
23546607 - JAMA Intern Med. 2013 May 13;173(9):743-52
25107684 - J Cyst Fibros. 2015 Jan;14 (1):97-103
22006666 - Pediatr Pulmonol. 2012 Feb;47(2):105-12
25338662 - Thromb Haemost. 2015 Mar;113(3):599-604
21781254 - J Thromb Haemost. 2011 Jul;9 Suppl 1:182-8
26148433 - Eur J Intern Med. 2015 Sep;26(7):528-33
19128254 - Wound Repair Regen. 2008 Sep-Oct;16(5):585-601
6465474 - Am J Pediatr Hematol Oncol. 1984 Summer;6(2):210-2
25949215 - Thromb J. 2015 May 06;13:17
22477540 - Int J Hematol. 2012 Apr;95(4):346-52
16737881 - J Pediatr. 2006 May;148(5):659-64
25590524 - Semin Thromb Hemost. 2015 Feb;41(1):9-15
1557263 - Pediatrics. 1992 Apr;89(4 Pt 2):691-5
20016997 - Cell Mol Life Sci. 2010 Feb;67(4):499-511
18032692 - J Leukoc Biol. 2008 Mar;83(3):536-45
27942589 - JCI Insight. 2016 Dec 8;1(20):e89384
15794972 - Lancet. 2005 Mar 26-Apr 1;365(9465):1163-74
25414432 - Blood. 2014 Nov 20;124(22):3177-8
18068560 - J Vasc Surg. 2007 Dec;46 Suppl S:25S-53S
1885073 - Gut. 1991 Aug;32(8):913-7
21620438 - Thromb Res. 2011 Sep;128(3):216-20
20031567 - Circ Cardiovasc Genet. 2009 Feb;2(1):57-62
23222502 - Nat Rev Immunol. 2013 Jan;13(1):34-45
26707513 - J Thromb Haemost. 2016 Mar;14 (3):427-37
20833120 - Orthop Traumatol Surg Res. 2010 Dec;96(8):890-3
19031531 - Nat Chem Biol. 2008 Dec;4(12):742-50
14522404 - Cardiovasc Res. 2003 Oct 15;60(1):26-39
26709039 - Thromb Res. 2016 Feb;138:69-73
25696835 - Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):60-5
25252703 - Rheumatology (Oxford). 2015 Apr;54(4):736-42
References_xml – volume: 138
  start-page: 69
  year: 2016
  ident: B11
  article-title: Clinical variables and Staphylococcus aureus virulence factors associated with venous thromboembolism in children
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2015.11.029
– volume: 96
  start-page: 890
  year: 2010
  ident: B81
  article-title: Deep venous thrombosis associated with acute hematogenous osteomyelitis in children
  publication-title: Orthop Traumatol Surg Res
  doi: 10.1016/j.otsr.2010.05.006
– volume: 16
  start-page: 435
  year: 2014
  ident: B22
  article-title: A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-014-0435-y
– volume: 365
  start-page: 1163
  year: 2005
  ident: B32
  article-title: Deep vein thrombosis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)71880-8
– volume: 9
  start-page: 1326
  year: 2011
  ident: B51
  article-title: Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2011.04354.x
– volume: 122
  start-page: 3415
  year: 2013
  ident: B71
  article-title: Inflammation, obesity, and thrombosis
  publication-title: Blood
  doi: 10.1182/blood-2013-05-427708
– volume: 13
  start-page: 34
  year: 2013
  ident: B48
  article-title: Thrombosis as an intravascular effector of innate immunity
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3345
– volume: 42
  start-page: 1557
  year: 1997
  ident: B68
  article-title: Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies
  publication-title: Dig Dis Sci
  doi: 10.1023/A:1018895500721
– volume: 26
  start-page: 306
  year: 2007
  ident: B28
  article-title: The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis
  publication-title: Int Angiol
– volume: 15
  start-page: 328
  year: 2009
  ident: B69
  article-title: Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naive ulcerative colitis during active and quiescent disease
  publication-title: Inflamm Bowel Dis
  doi: 10.1002/ibd.20759
– volume: 70
  start-page: 7
  year: 2003
  ident: B36
  article-title: Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis
  publication-title: Respiration
  doi: 10.1159/000068427
– volume: 60
  start-page: 26
  year: 2003
  ident: B12
  article-title: Infection and inflammation and the coagulation system
  publication-title: Cardiovasc Res
  doi: 10.1016/S0008-6363(02)00857-X
– volume: 37
  start-page: 31
  year: 2015
  ident: B44
  article-title: Polyphosphate, platelets, and coagulation
  publication-title: Int J Lab Hematol
  doi: 10.1111/ijlh.12349
– volume: 34
  start-page: 5
  year: 2012
  ident: B50
  article-title: Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum
  publication-title: Semin Immunopathol
  doi: 10.1007/s00281-011-0286-4
– volume: 2
  start-page: 57
  year: 2009
  ident: B82
  article-title: An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of venous thromboembolism: The Women's Genome Health Study
  publication-title: Circ Cardiovasc Genet
  doi: 10.1161/CIRCGENETICS.108.801969
– volume: 15
  start-page: 2289
  year: 2017
  ident: B34
  article-title: Tissue fator-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer
  publication-title: J Thromb Haemost
  doi: 10.1111/jth.13871
– volume: 14
  start-page: 97
  year: 2015
  ident: B5
  article-title: Central venous thrombosis and thrombophilia in cystic fibrosis: a prospective study
  publication-title: J Cyst Fibros
  doi: 10.1016/j.jcf.2014.05.015
– volume: 41
  start-page: 9
  year: 2015
  ident: B78
  article-title: Coagulation in patients with severe sepsis
  publication-title: Semin Thromb Hemost
  doi: 10.1055/s-0034-1398376
– volume: 39
  start-page: 152
  year: 1968
  ident: B56
  article-title: Human wound repair. II. Inflammatory cells, epithelial-mesenchymal interrelations, and fibrogenesis
  publication-title: J Cell Biol
  doi: 10.1083/jcb.39.1.152
– volume: 6
  start-page: 210
  year: 1984
  ident: B74
  article-title: Transitory anticoagulants in healthy children
  publication-title: Am J Pediatr Hematol Oncol
  doi: 10.1097/00043426-198406020-00017
– volume: 158
  start-page: 161
  year: 2017
  ident: B7
  article-title: Venous thromboembolism in children with cystic fibrosis: retrospective incidence and intrapopulation risk factors
  publication-title: Thromb Res.
  doi: 10.1016/j.thromres.2017.08.022
– volume: 95
  start-page: 346
  year: 2012
  ident: B43
  article-title: Polyphosphate: a link between platelets, coagulation and inflammation
  publication-title: Int J Hematol
  doi: 10.1007/s12185-012-1054-5
– volume: 38
  start-page: 871
  year: 2007
  ident: B38
  article-title: Pulmonary thromboendarterectomy: a clinicopathologic study of 200 consecutive pulmonary thromboendarterectomy cases in one institution
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2006.11.017
– volume: 39
  start-page: 461
  year: 2013
  ident: B17
  article-title: Risk of venous thromboembolism in patients with inflammatory bowel disease
  publication-title: Semin Thromb Hemost
  doi: 10.1055/s-0033-1343886
– volume: 33
  start-page: 1715
  year: 2006
  ident: B21
  article-title: Lupus and thrombosis
  publication-title: J Rheumatol
– volume: 8
  start-page: 1
  year: 1999
  ident: B57
  article-title: Mast cells and their mediators in cutaneous wound healing–active participants or innocent bystanders?
  publication-title: Exp Dermatol
  doi: 10.1111/j.1600-0625.1999.tb00342.x
– volume: 24
  start-page: 4575
  year: 2006
  ident: B13
  article-title: Catheter-related deep venous thrombosis and other catheter complications in children with cancer
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.05.5343
– volume: 32
  start-page: 1777
  year: 2012
  ident: B47
  article-title: Neutrophil extracellular trap (NET) impact on deep vein thrombosis
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.111.242859
– volume: 47
  start-page: 105
  year: 2012
  ident: B6
  article-title: Venous thromboembolism in cystic fibrosis
  publication-title: Pediatr Pulmonol
  doi: 10.1002/ppul.21566
– volume: 117
  start-page: 1171
  year: 2017
  ident: B66
  article-title: E-selectin inhibition with GMI-1271 decreases venous thrombosis without profoundly affecting tail vein bleeding in a mouse model
  publication-title: Thromb Haemost
  doi: 10.1160/TH16-04-0323
– volume: 57
  start-page: 497
  year: 2014
  ident: B3
  article-title: Infection and venous thromboembolism in patients undergoing colorectal surgery: what is the relationship?
  publication-title: Dis Colon Rectum
  doi: 10.1097/DCR.0000000000000054
– volume: 102
  start-page: 615
  year: 2009
  ident: B24
  article-title: C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort
  publication-title: Thromb Haemost
  doi: 10.1160/TH09-04-0274
– volume: 14
  start-page: 427
  year: 2016
  ident: B29
  article-title: Contact system revisited: an interface between inflammation, coagulation, and innate immunity
  publication-title: J Thromb Haemost
  doi: 10.1111/jth.13235
– volume: 128
  start-page: 2388
  year: 2016
  ident: B70
  article-title: Thrombosis in the setting of obesity or inflammatory bowel disease
  publication-title: Blood
  doi: 10.1182/blood-2016-05-716720
– volume: 9
  start-page: 182
  year: 2011
  ident: B46
  article-title: Innate immunity and coagulation
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2011.04323.x
– volume: 89
  start-page: 691
  year: 1992
  ident: B73
  article-title: Preoperative history and coagulation screening in children undergoing tonsillectomy
  publication-title: Pediatrics
  doi: 10.1097/00132586-199212000-00035
– volume: 9
  start-page: 283
  year: 2004
  ident: B60
  article-title: Wound healing: an overview of acute, fibrotic and delayed healing
  publication-title: Front Biosci
  doi: 10.2741/1184
– volume: 2
  start-page: 619
  year: 2004
  ident: B62
  article-title: Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2004.00689.x
– volume: 46
  start-page: 25S
  year: 2007
  ident: B37
  article-title: Acute venous disease: venous thrombosis and venous trauma
  publication-title: J Vasc Surg
  doi: 10.1016/j.jvs.2007.08.037
– volume: 28
  start-page: 387
  year: 2008
  ident: B33
  article-title: Mechanisms of venous thrombosis and resolution
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.108.162289
– volume: 32
  start-page: 913
  year: 1991
  ident: B67
  article-title: Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease
  publication-title: Gut
  doi: 10.1136/gut.32.8.913
– volume: 54
  start-page: 736
  year: 2015
  ident: B52
  article-title: Non-steroidal anti-inflammatory drugs and risk of venous thromboembolism: a systematic review and meta-analysis
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keu408
– volume: 2012
  start-page: 428269
  year: 2012
  ident: B19
  article-title: Thrombosis in systemic lupus erythematosus: a review article
  publication-title: ISRN Rheumatol
  doi: 10.5402/2012/428269
– volume: 113
  start-page: 599
  year: 2015
  ident: B41
  article-title: Polyphosphate accelerates factor V activation by factor XIa
  publication-title: Thromb Haemost
  doi: 10.1160/TH14-06-0515
– volume: 12
  start-page: 1993
  year: 2014
  ident: B4
  article-title: Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort
  publication-title: J Thromb Haemost.
  doi: 10.1111/jth.12742
– volume: 16
  start-page: 13
  year: 2015
  ident: B20
  article-title: Systemic lupus erythematosus and thrombosis
  publication-title: Thromb J
  doi: 10.1186/s12959-015-0043-3
– volume: 110
  start-page: IV4
  year: 2004
  ident: B1
  article-title: Prevention of venous thromboembolism in surgical patients
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000150639.98514.6c
– volume: 31
  start-page: 625
  year: 2016
  ident: B25
  article-title: The correlation analysis of tumor necrosis factor-alpha-308G/A polymorphism and venous thromboembolism risk: a meta-analysis
  publication-title: Phlebology
  doi: 10.1177/0268355515607405
– volume: 87
  start-page: 2420
  year: 2007
  ident: B39
  article-title: An study on screening the gene clusters associated with pulmonary embolism-deep venous thrombosis by oligo microarray
  publication-title: Zhonghua Yi Xue Za Zhi
– volume: 141
  start-page: e227S
  year: 2012
  ident: B2
  article-title: Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest physicians evidence-based clinical practice guidelines
  publication-title: Chest
  doi: 10.1378/chest.11-2297
– volume: 36
  start-page: 928
  year: 2002
  ident: B65
  publication-title: J Vasc Surg
  doi: 10.1067/mva.2002.128636
– volume: 106
  start-page: 713
  year: 2011
  ident: B18
  article-title: Venous thromboembolism in inflammatory bowel disease: an epidemiological review
  publication-title: Am J Gastroenterol
  doi: 10.1038/ajg.2011.53
– volume: 28
  start-page: 655
  year: 2015
  ident: B23
  article-title: Inflammation in venous thromboembolism: Cause or consequence?
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2015.07.044
– volume: 13
  start-page: e23
  year: 2011
  ident: B55
  article-title: Inflammation and wound healing: the role of the macrophage
  publication-title: Expert Rev Mol Med
  doi: 10.1017/S1462399411001943
– volume: 3
  start-page: 143
  year: 2013
  ident: B77
  article-title: Catheter-Associated Venous Thromboembolism in Patients with Cystic Fibrosis
  publication-title: J Pulmon Resp Med
  doi: 10.4172/2161-105X.1000143
– volume: 4
  start-page: 742
  year: 2008
  ident: B80
  article-title: Spatial localization of bacteria controls coagulation of human blood by ’quorum acting’
  publication-title: Nat. Chem. Biol
  doi: 10.1038/nchembio.124
– volume: 173
  start-page: 483
  year: 2006
  ident: B75
  article-title: The inflammatory role of platelets in cystic fibrosis
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200508-1243PP
– volume: 39
  start-page: 559
  year: 2013
  ident: B8
  article-title: Sepsis and thrombosis
  publication-title: Semin Thromb Hemost
  doi: 10.1055/s-0033-1343894
– volume: 16
  start-page: 585
  year: 2008
  ident: B59
  article-title: Growth factors and cytokines in wound healing
  publication-title: Wound Repair Regen
  doi: 10.1111/j.1524-475X.2008.00410.x
– volume: 133
  start-page: 340
  year: 2014
  ident: B15
  article-title: Venous thromboembolism in children with cancer - a population-based cohort study
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2013.12.021
– volume: 20
  start-page: 102
  year: 2015
  ident: B40
  article-title: Beyond Virchow's Triad: does cardiovascular inflammation explain the recurrent nature of venous thromboembolism?
  publication-title: Vasc Med
  doi: 10.1177/1358863X14568706
– volume: 30
  start-page: 8
  year: 2010
  ident: B45
  article-title: Inflammation, innate immunity and blood coagulation
  publication-title: Hamostaseologie
  doi: 10.1055/s-0037-1617146
– volume: 83
  start-page: 536
  year: 2008
  ident: B10
  article-title: Inflammation, endothelium, and coagulation in sepsis
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.0607373
– volume: 13
  start-page: 17
  year: 2015
  ident: B31
  article-title: Contact pathway of coagulation and inflammation
  publication-title: Thromb J
  doi: 10.1186/s12959-015-0048-y
– volume: 209
  start-page: 479
  year: 1989
  ident: B58
  article-title: The effect of in vivo T helper and T suppressor lymphocyte depletion on wound healing
  publication-title: Ann Surg
  doi: 10.1097/00000658-198904000-00015
– volume: 20
  start-page: 437
  year: 2013
  ident: B72
  article-title: Mechanisms of thrombosis in obesity
  publication-title: Curr Opin Hematol
  doi: 10.1097/MOH.0b013e3283634443
– volume: 42
  start-page: 329
  year: 2005
  ident: B64
  article-title: Decreased venous thrombosis with an oral inhibitor of P selectin
  publication-title: J Vasc Surg
  doi: 10.1016/j.jvs.2005.04.045
– volume: 148
  start-page: 659
  year: 2006
  ident: B76
  article-title: Cystic fibrosis as a risk factor for recurrent venous thrombosis at a pediatric tertiary care hospital
  publication-title: J Pediatr
  doi: 10.1016/j.jpeds.2005.11.032
– volume: 26
  start-page: 528
  year: 2015
  ident: B54
  article-title: Venous thromboembolism and preoperative steroid use: analysis of the NSQIP database to evaluate risk in surgical patients
  publication-title: Eur J Intern Med
  doi: 10.1016/j.ejim.2015.06.005
– volume: 173
  start-page: 743
  year: 2013
  ident: B53
  article-title: Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study
  publication-title: JAMA Intern Med
  doi: 10.1001/jamainternmed.2013.122
– volume: 67
  start-page: 499
  year: 2010
  ident: B49
  article-title: Platelets and innate immunity
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-009-0205-1
– volume: 13
  start-page: 14
  year: 2015
  ident: B16
  article-title: Thrombosis in inflammatory bowel diseases: what's the link?
  publication-title: Thromb J
  doi: 10.1186/s12959-015-0044-2
– volume: 128
  start-page: 216
  year: 2011
  ident: B27
  article-title: The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6−174GC, IL-8−251AT and MCP-1−2518AG in the risk of venous thromboembolism: a case-control study
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2011.04.016
– volume: 124
  start-page: 3177
  year: 2014
  ident: B42
  article-title: Polyphosphate: a target for thrombosis attenuation
  publication-title: Blood
  doi: 10.1182/blood-2014-09-601641
– volume: 2014
  start-page: 60
  year: 2014
  ident: B30
  article-title: Recent insights into the role of the contact pathway in thrombo-inflammatory disorders
  publication-title: Hematol Am Soc Hematol Educ Program
  doi: 10.1182/asheducation-2014.1.60
– volume: 73
  start-page: 515
  year: 2011
  ident: B35
  article-title: Role of tissue factor in venous thrombosis
  publication-title: Annu Rev Physiol
  doi: 10.1146/annurev-physiol-042210-121137
– volume: 1
  start-page: e89384
  year: 2016
  ident: B61
  article-title: Interleukin 6 regulates psoriasiform inflammation-associated thrombosis
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.89384
– volume: 118
  start-page: 1392
  year: 2016
  ident: B79
  article-title: Cross talk pathways between coagulation and inflammation
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.116.306853
– volume: 39
  start-page: 1839
  year: 2013
  ident: B9
  article-title: Endothelial injury in sepsis
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-013-3054-1
– volume: 125
  start-page: 3997
  year: 2012
  ident: B26
  article-title: Association of interleukin-6 and C-reactive protein genetic polymorphisms levels with venous thromboembolism
  publication-title: Chin Med J
  doi: 10.3760/cma.j.issn.0366-6999.2012.22.016
– volume: 12
  start-page: 860
  year: 2014
  ident: B63
  article-title: Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development
  publication-title: J Thromb Haemost
  doi: 10.1111/jth.12571
– volume: 6
  start-page: 589
  year: 2008
  ident: B14
  article-title: Prevalence of post-thrombotic syndrome following asymptomatic thrombosis in survivors of acute lymphoblastic leukemia
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2008.02901.x
– reference: 23158132 - Chin Med J (Engl). 2012 Nov;125(22):3997-4002
– reference: 25949215 - Thromb J. 2015 May 06;13:17
– reference: 19806245 - Thromb Haemost. 2009 Oct;102(4):615-9
– reference: 22315263 - Chest. 2012 Feb;141(2 Suppl):e227S-e277S
– reference: 16737881 - J Pediatr. 2006 May;148(5):659-64
– reference: 6465474 - Am J Pediatr Hematol Oncol. 1984 Summer;6(2):210-2
– reference: 2522759 - Ann Surg. 1989 Apr;209(4):479-83
– reference: 25414432 - Blood. 2014 Nov 20;124(22):3177-8
– reference: 19128254 - Wound Repair Regen. 2008 Sep-Oct;16(5):585-601
– reference: 24388573 - Thromb Res. 2014 Mar;133(3):340-4
– reference: 22652600 - Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1777-83
– reference: 20833120 - Orthop Traumatol Surg Res. 2010 Dec;96(8):890-3
– reference: 5678446 - J Cell Biol. 1968 Oct;39(1):152-68
– reference: 25590524 - Semin Thromb Hemost. 2015 Feb;41(1):9-15
– reference: 20031567 - Circ Cardiovasc Genet. 2009 Feb;2(1):57-62
– reference: 18194413 - J Thromb Haemost. 2008 Apr;6(4):589-94
– reference: 22477540 - Int J Hematol. 2012 Apr;95(4):346-52
– reference: 27942589 - JCI Insight. 2016 Dec 8;1(20):e89384
– reference: 23817170 - Curr Opin Hematol. 2013 Sep;20(5):437-44
– reference: 22900201 - ISRN Rheumatol. 2012;2012:428269
– reference: 18296594 - Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):387-91
– reference: 18068560 - J Vasc Surg. 2007 Dec;46 Suppl S:25S-53S
– reference: 18091697 - Int Angiol. 2007 Dec;26(4):306-11
– reference: 20016997 - Cell Mol Life Sci. 2010 Feb;67(4):499-511
– reference: 28300869 - Thromb Haemost. 2017 Jun 2;117(6):1171-1181
– reference: 26148433 - Eur J Intern Med. 2015 Sep;26(7):528-33
– reference: 18032692 - J Leukoc Biol. 2008 Mar;83(3):536-45
– reference: 9246063 - Dig Dis Sci. 1997 Jul;42(7):1557-66
– reference: 25976958 - Int J Lab Hematol. 2015 May;37 Suppl 1:31-5
– reference: 1557263 - Pediatrics. 1992 Apr;89(4 Pt 2):691-5
– reference: 23629820 - Semin Thromb Hemost. 2013 Jul;39(5):461-8
– reference: 26709039 - Thromb Res. 2016 Feb;138:69-73
– reference: 25832597 - Vasc Med. 2015 Apr;20(2):102-4
– reference: 23546607 - JAMA Intern Med. 2013 May 13;173(9):743-52
– reference: 27856470 - Blood. 2016 Nov 17;128(20):2388-2394
– reference: 22006666 - Pediatr Pulmonol. 2012 Feb;47(2):105-12
– reference: 26707513 - J Thromb Haemost. 2016 Mar;14 (3):427-37
– reference: 14522404 - Cardiovasc Res. 2003 Oct 15;60(1):26-39
– reference: 18036322 - Zhonghua Yi Xue Za Zhi. 2007 Sep 11;87(34):2420-2
– reference: 16960931 - J Rheumatol. 2006 Sep;33(9):1715-7
– reference: 23625756 - Semin Thromb Hemost. 2013 Jul;39(5):559-66
– reference: 21818701 - Semin Immunopathol. 2012 Jan;34(1):5-30
– reference: 25696835 - Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):60-5
– reference: 27126649 - Circ Res. 2016 Apr 29;118(9):1392-408
– reference: 25253302 - Arthritis Res Ther. 2014 Sep 25;16(5):435
– reference: 23222502 - Nat Rev Immunol. 2013 Jan;13(1):34-45
– reference: 21592304 - J Thromb Haemost. 2011 Jul;9(7):1326-33
– reference: 21740602 - Expert Rev Mol Med. 2011 Jul 11;13:e23
– reference: 18942752 - Inflamm Bowel Dis. 2009 Mar;15(3):328-34
– reference: 20690821 - Annu Rev Physiol. 2011;73:515-25
– reference: 21781254 - J Thromb Haemost. 2011 Jul;9 Suppl 1:182-8
– reference: 25908929 - Thromb J. 2015 Apr 23;13:16
– reference: 25866483 - Thromb J. 2015 Apr 02;13:14
– reference: 26405065 - Phlebology. 2016 Oct;31(9):625-31
– reference: 10206716 - Exp Dermatol. 1999 Feb;8(1):1-16
– reference: 23925547 - Intensive Care Med. 2013 Oct;39(10 ):1839-42
– reference: 21407182 - Am J Gastroenterol. 2011 Apr;106(4):713-8
– reference: 24674135 - J Thromb Haemost. 2014 Jun;12(6):860-70
– reference: 24608307 - Dis Colon Rectum. 2014 Apr;57(4):497-505
– reference: 19031531 - Nat Chem Biol. 2008 Dec;4(12):742-50
– reference: 28934665 - Thromb Res. 2017 Oct;158:161-166
– reference: 17350667 - Hum Pathol. 2007 Jun;38(6):871-7
– reference: 14766366 - Front Biosci. 2004 Jan 01;9:283-9
– reference: 21620438 - Thromb Res. 2011 Sep;128(3):216-20
– reference: 16102635 - J Vasc Surg. 2005 Aug;42(2):329-36
– reference: 1885073 - Gut. 1991 Aug;32(8):913-7
– reference: 26253657 - Int Immunopharmacol. 2015 Sep;28(1):655-65
– reference: 24092932 - Blood. 2013 Nov 14;122(20):3415-22
– reference: 20162248 - Hamostaseologie. 2010 Jan;30(1):5-6, 8-9
– reference: 25292154 - J Thromb Haemost. 2014 Dec;12(12):1993-2001
– reference: 29028284 - J Thromb Haemost. 2017 Dec;15(12 ):2289-2299
– reference: 25252703 - Rheumatology (Oxford). 2015 Apr;54(4):736-42
– reference: 25338662 - Thromb Haemost. 2015 Mar;113(3):599-604
– reference: 12584387 - Respiration. 2003 Jan-Feb;70(1):7-30
– reference: 16339920 - Am J Respir Crit Care Med. 2006 Mar 1;173(5):483-90
– reference: 15102017 - J Thromb Haemost. 2004 Apr;2(4):619-22
– reference: 15794972 - Lancet. 2005 Mar 26-Apr 1;365(9465):1163-74
– reference: 12422103 - J Vasc Surg. 2002 Nov;36(5):928-38
– reference: 25107684 - J Cyst Fibros. 2015 Jan;14 (1):97-103
– reference: 17008698 - J Clin Oncol. 2006 Oct 1;24(28):4575-80
– reference: 15598646 - Circulation. 2004 Dec 14;110(24 Suppl 1):IV4-12
SSID ssj0000970515
Score 2.541271
SecondaryResourceType review_article
Snippet Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT), and pulmonary embolism (PE), is becoming increasingly recognized as a cause of morbidity...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 142
SubjectTerms cytokines
inflammation
Pediatrics
platelets
thrombosis
venous thromboembolism
Title The Role of Inflammation in Venous Thromboembolism
URI https://www.ncbi.nlm.nih.gov/pubmed/29876337
https://www.proquest.com/docview/2051657445
https://pubmed.ncbi.nlm.nih.gov/PMC5974100
https://doaj.org/article/28befc0c855a491f91956a90ff90fc66
Volume 6
WOSCitedRecordID wos000432836100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2296-2360
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000970515
  issn: 2296-2360
  databaseCode: DOA
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2296-2360
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000970515
  issn: 2296-2360
  databaseCode: M~E
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwEB2VqkJcEC1fAVqlEgcuobHXju0joFb00KpCBe0tsse2utI2qbYLx_72jp10tYtAXDg4h8SRnfeSzIw8fgPwXiDXsZGyUh6xIhNgK60lr0KURgunGEOfi02o83M9nZqLtVJfKSdskAcegDvi2oWINWoprTAsmrTBzZo6RmrYZLFt8nrWgqn8DzYqFS8ZtHwoCjNH8SYkYVCWUieZ4BtmKKv1_8nF_D1Tcs30nDyDp6PPWH4a5roLW6Hbg8dn46r4c-DEdfmtn4eyj-VpF4nkYUNiOevKH1mEtby8WvTXrg_U5rPb6xfw_eT48svXaqyFUKHkclk5tN5FzjAyemzBmJ8Y7dC7IKKQzjkvlPXKNI4h89pyNIGcD00elfWWbPJL2O76LryGkhwEO3FOCCWciOSgodTOCGy4qgO5IwV8fICmxVEoPNWrmLcUMCQs24Rlm7BsM5YFfFjdcDNoZPy96-eE9apbErfOJ4jydqS8_RflBRw-MNXSx5BWOGwXCEsaSLJGKiFkAa8G5lZDcZPE9yaqALXB6cZcNq90s6ssuJ2CLlbXb_7H5N_CkwRHSkDgk3ewvVz8DPuwg7-Ws9vFATxSU32Q32U6nt0d3wMtGPnL
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Role+of+Inflammation+in+Venous+Thromboembolism&rft.jtitle=Frontiers+in+pediatrics&rft.au=Brian+R.+Branchford&rft.au=Shannon+L.+Carpenter&rft.date=2018-05-23&rft.pub=Frontiers+Media+S.A&rft.eissn=2296-2360&rft.volume=6&rft_id=info:doi/10.3389%2Ffped.2018.00142&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_28befc0c855a491f91956a90ff90fc66
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2296-2360&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2296-2360&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2296-2360&client=summon